ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CAR T-Cell-Based Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15F13961
Home | Market Reports | Health| Pharmacy
Global CAR T Cell Based Drug Market Research Report 2023
BUY CHAPTERS

Global CAR T-Cell-Based Drug Market Research Report 2025

Code: QYRE-Auto-15F13961
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Gilead Sciences
Bristol–Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird bio
CELLECTIS
Allogene Therapeutics
Celyad

CAR T-Cell-Based Drug Market Size

The global market for CAR T-Cell-Based Drug was valued at US$ 5168 million in the year 2024 and is projected to reach a revised size of US$ 30680 million by 2031, growing at a CAGR of 29.4% during the forecast period.

CAR T-Cell-Based Drug Market

CAR T-Cell-Based Drug Market

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient"s T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
This report aims to provide a comprehensive presentation of the global market for CAR T-Cell-Based Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell-Based Drug.
The CAR T-Cell-Based Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR T-Cell-Based Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR T-Cell-Based Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CAR T-Cell-Based Drug Market Report

Report Metric Details
Report Name CAR T-Cell-Based Drug Market
Accounted market size in year US$ 5168 million
Forecasted market size in 2031 US$ 30680 million
CAGR 29.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • CD19-targeted
  • BCMA-targeted
Segment by Application
  • Lymphoma
  • Multiple Myeloma
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics, Sorrento Therapeutics, Mustang Bio, Bluebird Bio, Cellectis, Allogene Therapeutics, Celyad
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CAR T-Cell-Based Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CAR T-Cell-Based Drug Market growing?

Ans: The CAR T-Cell-Based Drug Market witnessing a CAGR of 29.4% during the forecast period 2025-2031.

What is the CAR T-Cell-Based Drug Market size in 2031?

Ans: The CAR T-Cell-Based Drug Market size in 2031 will be US$ 30680 million.

Who are the main players in the CAR T-Cell-Based Drug Market report?

Ans: The main players in the CAR T-Cell-Based Drug Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics, Sorrento Therapeutics, Mustang Bio, Bluebird Bio, Cellectis, Allogene Therapeutics, Celyad

What are the Application segmentation covered in the CAR T-Cell-Based Drug Market report?

Ans: The Applications covered in the CAR T-Cell-Based Drug Market report are Lymphoma, Multiple Myeloma

What are the Type segmentation covered in the CAR T-Cell-Based Drug Market report?

Ans: The Types covered in the CAR T-Cell-Based Drug Market report are CD19-targeted, BCMA-targeted

Recommended Reports

CAR-T Therapies

Cell Immunotherapy

T-cell Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell-Based Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell-Based Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell-Based Drug Market Perspective (2020-2031)
2.2 Global CAR T-Cell-Based Drug Growth Trends by Region
2.2.1 Global CAR T-Cell-Based Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR T-Cell-Based Drug Historic Market Size by Region (2020-2025)
2.2.3 CAR T-Cell-Based Drug Forecasted Market Size by Region (2026-2031)
2.3 CAR T-Cell-Based Drug Market Dynamics
2.3.1 CAR T-Cell-Based Drug Industry Trends
2.3.2 CAR T-Cell-Based Drug Market Drivers
2.3.3 CAR T-Cell-Based Drug Market Challenges
2.3.4 CAR T-Cell-Based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell-Based Drug Players by Revenue
3.1.1 Global Top CAR T-Cell-Based Drug Players by Revenue (2020-2025)
3.1.2 Global CAR T-Cell-Based Drug Revenue Market Share by Players (2020-2025)
3.2 Global CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR T-Cell-Based Drug Revenue
3.4 Global CAR T-Cell-Based Drug Market Concentration Ratio
3.4.1 Global CAR T-Cell-Based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell-Based Drug Revenue in 2024
3.5 Global Key Players of CAR T-Cell-Based Drug Head office and Area Served
3.6 Global Key Players of CAR T-Cell-Based Drug, Product and Application
3.7 Global Key Players of CAR T-Cell-Based Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell-Based Drug Breakdown Data by Type
4.1 Global CAR T-Cell-Based Drug Historic Market Size by Type (2020-2025)
4.2 Global CAR T-Cell-Based Drug Forecasted Market Size by Type (2026-2031)
5 CAR T-Cell-Based Drug Breakdown Data by Application
5.1 Global CAR T-Cell-Based Drug Historic Market Size by Application (2020-2025)
5.2 Global CAR T-Cell-Based Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR T-Cell-Based Drug Market Size (2020-2031)
6.2 North America CAR T-Cell-Based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR T-Cell-Based Drug Market Size by Country (2020-2025)
6.4 North America CAR T-Cell-Based Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell-Based Drug Market Size (2020-2031)
7.2 Europe CAR T-Cell-Based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR T-Cell-Based Drug Market Size by Country (2020-2025)
7.4 Europe CAR T-Cell-Based Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell-Based Drug Market Size (2020-2031)
8.2 Asia-Pacific CAR T-Cell-Based Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell-Based Drug Market Size (2020-2031)
9.2 Latin America CAR T-Cell-Based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR T-Cell-Based Drug Market Size by Country (2020-2025)
9.4 Latin America CAR T-Cell-Based Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell-Based Drug Market Size (2020-2031)
10.2 Middle East & Africa CAR T-Cell-Based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell-Based Drug Introduction
11.1.4 Novartis Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell-Based Drug Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell-Based Drug Introduction
11.4.4 J & J Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell-Based Drug Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell-Based Drug Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Details
11.7.2 CARsgen Therapeutics Business Overview
11.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Introduction
11.7.4 CARsgen Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.7.5 CARsgen Therapeutics Recent Development
11.8 Autolus Therapeutics
11.8.1 Autolus Therapeutics Company Details
11.8.2 Autolus Therapeutics Business Overview
11.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Introduction
11.8.4 Autolus Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.8.5 Autolus Therapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Details
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Introduction
11.9.4 Sorrento Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Mustang Bio
11.10.1 Mustang Bio Company Details
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio CAR T-Cell-Based Drug Introduction
11.10.4 Mustang Bio Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.10.5 Mustang Bio Recent Development
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Details
11.11.2 Bluebird Bio Business Overview
11.11.3 Bluebird Bio CAR T-Cell-Based Drug Introduction
11.11.4 Bluebird Bio Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.11.5 Bluebird Bio Recent Development
11.12 Cellectis
11.12.1 Cellectis Company Details
11.12.2 Cellectis Business Overview
11.12.3 Cellectis CAR T-Cell-Based Drug Introduction
11.12.4 Cellectis Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.12.5 Cellectis Recent Development
11.13 Allogene Therapeutics
11.13.1 Allogene Therapeutics Company Details
11.13.2 Allogene Therapeutics Business Overview
11.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Introduction
11.13.4 Allogene Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.13.5 Allogene Therapeutics Recent Development
11.14 Celyad
11.14.1 Celyad Company Details
11.14.2 Celyad Business Overview
11.14.3 Celyad CAR T-Cell-Based Drug Introduction
11.14.4 Celyad Revenue in CAR T-Cell-Based Drug Business (2020-2025)
11.14.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Gilead Sciences
Bristol–Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird bio
CELLECTIS
Allogene Therapeutics
Celyad
List of Tables
 Table 1. Global CAR T-Cell-Based Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of CD19-targeted
 Table 3. Key Players of BCMA-targeted
 Table 4. Global CAR T-Cell-Based Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global CAR T-Cell-Based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global CAR T-Cell-Based Drug Market Share by Region (2020-2025)
 Table 8. Global CAR T-Cell-Based Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global CAR T-Cell-Based Drug Market Share by Region (2026-2031)
 Table 10. CAR T-Cell-Based Drug Market Trends
 Table 11. CAR T-Cell-Based Drug Market Drivers
 Table 12. CAR T-Cell-Based Drug Market Challenges
 Table 13. CAR T-Cell-Based Drug Market Restraints
 Table 14. Global CAR T-Cell-Based Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global CAR T-Cell-Based Drug Market Share by Players (2020-2025)
 Table 16. Global Top CAR T-Cell-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2024)
 Table 17. Ranking of Global Top CAR T-Cell-Based Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by CAR T-Cell-Based Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of CAR T-Cell-Based Drug, Headquarters and Area Served
 Table 20. Global Key Players of CAR T-Cell-Based Drug, Product and Application
 Table 21. Global Key Players of CAR T-Cell-Based Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global CAR T-Cell-Based Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global CAR T-Cell-Based Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global CAR T-Cell-Based Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global CAR T-Cell-Based Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global CAR T-Cell-Based Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global CAR T-Cell-Based Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global CAR T-Cell-Based Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global CAR T-Cell-Based Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America CAR T-Cell-Based Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe CAR T-Cell-Based Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific CAR T-Cell-Based Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America CAR T-Cell-Based Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa CAR T-Cell-Based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Novartis Company Details
 Table 47. Novartis Business Overview
 Table 48. Novartis CAR T-Cell-Based Drug Product
 Table 49. Novartis Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 50. Novartis Recent Development
 Table 51. Gilead Sciences Company Details
 Table 52. Gilead Sciences Business Overview
 Table 53. Gilead Sciences CAR T-Cell-Based Drug Product
 Table 54. Gilead Sciences Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 55. Gilead Sciences Recent Development
 Table 56. Bristol-Myers Squibb Company Details
 Table 57. Bristol-Myers Squibb Business Overview
 Table 58. Bristol-Myers Squibb CAR T-Cell-Based Drug Product
 Table 59. Bristol-Myers Squibb Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 60. Bristol-Myers Squibb Recent Development
 Table 61. J & J Company Details
 Table 62. J & J Business Overview
 Table 63. J & J CAR T-Cell-Based Drug Product
 Table 64. J & J Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 65. J & J Recent Development
 Table 66. JW Therapeutics Company Details
 Table 67. JW Therapeutics Business Overview
 Table 68. JW Therapeutics CAR T-Cell-Based Drug Product
 Table 69. JW Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 70. JW Therapeutics Recent Development
 Table 71. FOSUNKite Company Details
 Table 72. FOSUNKite Business Overview
 Table 73. FOSUNKite CAR T-Cell-Based Drug Product
 Table 74. FOSUNKite Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 75. FOSUNKite Recent Development
 Table 76. CARsgen Therapeutics Company Details
 Table 77. CARsgen Therapeutics Business Overview
 Table 78. CARsgen Therapeutics CAR T-Cell-Based Drug Product
 Table 79. CARsgen Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 80. CARsgen Therapeutics Recent Development
 Table 81. Autolus Therapeutics Company Details
 Table 82. Autolus Therapeutics Business Overview
 Table 83. Autolus Therapeutics CAR T-Cell-Based Drug Product
 Table 84. Autolus Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 85. Autolus Therapeutics Recent Development
 Table 86. Sorrento Therapeutics Company Details
 Table 87. Sorrento Therapeutics Business Overview
 Table 88. Sorrento Therapeutics CAR T-Cell-Based Drug Product
 Table 89. Sorrento Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 90. Sorrento Therapeutics Recent Development
 Table 91. Mustang Bio Company Details
 Table 92. Mustang Bio Business Overview
 Table 93. Mustang Bio CAR T-Cell-Based Drug Product
 Table 94. Mustang Bio Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 95. Mustang Bio Recent Development
 Table 96. Bluebird Bio Company Details
 Table 97. Bluebird Bio Business Overview
 Table 98. Bluebird Bio CAR T-Cell-Based Drug Product
 Table 99. Bluebird Bio Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 100. Bluebird Bio Recent Development
 Table 101. Cellectis Company Details
 Table 102. Cellectis Business Overview
 Table 103. Cellectis CAR T-Cell-Based Drug Product
 Table 104. Cellectis Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 105. Cellectis Recent Development
 Table 106. Allogene Therapeutics Company Details
 Table 107. Allogene Therapeutics Business Overview
 Table 108. Allogene Therapeutics CAR T-Cell-Based Drug Product
 Table 109. Allogene Therapeutics Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 110. Allogene Therapeutics Recent Development
 Table 111. Celyad Company Details
 Table 112. Celyad Business Overview
 Table 113. Celyad CAR T-Cell-Based Drug Product
 Table 114. Celyad Revenue in CAR T-Cell-Based Drug Business (2020-2025) & (US$ Million)
 Table 115. Celyad Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. CAR T-Cell-Based Drug Picture
 Figure 2. Global CAR T-Cell-Based Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CAR T-Cell-Based Drug Market Share by Type: 2024 VS 2031
 Figure 4. CD19-targeted Features
 Figure 5. BCMA-targeted Features
 Figure 6. Global CAR T-Cell-Based Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global CAR T-Cell-Based Drug Market Share by Application: 2024 VS 2031
 Figure 8. Lymphoma Case Studies
 Figure 9. Multiple Myeloma Case Studies
 Figure 10. CAR T-Cell-Based Drug Report Years Considered
 Figure 11. Global CAR T-Cell-Based Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global CAR T-Cell-Based Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global CAR T-Cell-Based Drug Market Share by Region: 2024 VS 2031
 Figure 14. Global CAR T-Cell-Based Drug Market Share by Players in 2024
 Figure 15. Global Top CAR T-Cell-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by CAR T-Cell-Based Drug Revenue in 2024
 Figure 17. North America CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America CAR T-Cell-Based Drug Market Share by Country (2020-2031)
 Figure 19. United States CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe CAR T-Cell-Based Drug Market Share by Country (2020-2031)
 Figure 23. Germany CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific CAR T-Cell-Based Drug Market Share by Region (2020-2031)
 Figure 31. China CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America CAR T-Cell-Based Drug Market Share by Country (2020-2031)
 Figure 39. Mexico CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa CAR T-Cell-Based Drug Market Share by Country (2020-2031)
 Figure 43. Turkey CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE CAR T-Cell-Based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Novartis Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 47. Gilead Sciences Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 48. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 49. J & J Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 50. JW Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 51. FOSUNKite Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 52. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 53. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 54. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 55. Mustang Bio Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 56. Bluebird Bio Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 57. Cellectis Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 58. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 59. Celyad Revenue Growth Rate in CAR T-Cell-Based Drug Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Drug based on CAR T Cell Market Research Report 2025
Global Drugs Based on CAR T cell Market Research Report 2025
Global CAR T cell Therapy Drug Market Research Report 2025
Global CAR T Cell Therapy Agents Market Research Report 2025
Cancer Drug based on CAR T Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CAR T Cellular Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CAR T Cell Therapy Market Research Report 2025
Global CAR T Cell Service Market Research Report 2024
Global CAR T Therapy for Hematological Cancer Market Research Report 2024
Global CAR T Cell Immunotherapy Market Insights Forecast to 2030
Global CD19 targeted CAR T Cell Therapy Market Research Report 2024
Global Autologous CAR T Cell Therapy Market Research Report 2024
Global CAR T Cell Development Service Market Research Report 2024
Global BCMA targeted CAR T Cell Therapy Market Research Report 2025
Global T Cell Immunotherapy Market Research Report 2025
Global CAR T Cell Manufacturing Service Market Research Report 2024
Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Modifying Immunotherapy for Blood Cancer Market Insights Forecast to 2030
Global TCR T Cellular Immunotherapy Market Research Report 2024
Global Cell Gene Therapy Biomanufacturing Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions